Details of the Drug
General Information of Drug (ID: DMLU8NX)
Drug Name |
Benserazide
|
|||||
---|---|---|---|---|---|---|
Synonyms |
benserazide; Serazide; 322-35-0; Benseraszide; Benserazida; Benserazidum; Ro 4-4602; Ro 44602; DL-Serine 2-(2,3,4-trihydroxybenzyl)hydrazide; Benserazidum [INN-Latin]; Benserazida [INN-Spanish]; Benserazide [USAN:INN:BAN]; DL-Seryltrihydroxybenzylhydrazine; C10H15N3O5; BRN 3984490; DL-Serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide; CHEBI:64187; DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide; Serine, 2-(2,3,4-trihydroxybenzyl)hyrazide, DL-; DL-serine 2-[(2,3,4-trihydroxyphenyl)methyl]hydrazide
|
|||||
Drug Type |
Small molecular drug
|
|||||
Structure | ||||||
3D MOL | 2D MOL | |||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 257.24 | ||||
Logarithm of the Partition Coefficient (xlogp) | -1.3 | |||||
Rotatable Bond Count (rotbonds) | 5 | |||||
Hydrogen Bond Donor Count (hbonddonor) | 7 | |||||
Hydrogen Bond Acceptor Count (hbondacc) | 7 | |||||
ADMET Property |
|
|||||
Chemical Identifiers |
|
|||||
Cross-matching ID | ||||||
Combinatorial Drugs (CBD) | Click to Jump to the Detailed CBD Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Off-Target (DOT) |
|
||||||||||||||||||||||||||
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
References